PTCE - Federal Requirements (18.75% of the exam) - Section 2.6

Apply FDA product serialisation, tracking, tracing, handling, and quarantining requirements under the Drug Supply Chain Security Act (DSCSA).

Apply Drug Supply Chain Security Act requirements for drug serialisation, transaction information documentation, and suspect product quarantine. Distinguish the tracing and notification obligations that a pharmacy must fulfil when a suspect or illegitimate product is identified in its supply chain.

DSCSADrug serialisationTransaction informationSuspect product quarantine

Practice question for this objective

Free sampleFederal Requirementsmedium

A wholesale shipment of atorvastatin tablets, lot ATV-7741, arrives at a community pharmacy. While reconciling the delivery, a technician finds that the supplier did not send the accompanying transaction information and transaction statement for several cartons in the order. Under DSCSA, what is the technician's correct next step before these cartons are placed into sellable stock?

  • APlace the cartons into sellable stock and request the missing transaction documents from the supplier within 30 days.
  • BHold the cartons as not received and decline to accept ownership until the transaction information and transaction statement are supplied. Correct
  • CDestroy the cartons immediately because product lacking transaction documents is automatically counterfeit.
  • DRepackage the cartons under the pharmacy's own lot number so they can be dispensed normally.
A dispenser must receive valid transaction information and a transaction statement before accepting ownership of a drug product under DSCSA. DSCSA conditions lawful acceptance of a product on the trading partner passing transaction information and a transaction statement at the point ownership transfers, so product arriving without that data cannot be taken into sellable inventory until the data is provided.

Why A is wrong: This is tempting because contacting the supplier is appropriate, but DSCSA prohibits accepting ownership of product without the required transaction data, so the product cannot enter sellable stock first.

Why B is correct: DSCSA requires that a dispenser receive the transaction information and transaction statement before or at the time of taking ownership, so product without that data must not be accepted into stock.

Why C is wrong: This overreacts: missing paperwork is a transaction-data failure, not proof of counterfeiting, and DSCSA does not direct immediate destruction without investigation.

Why D is wrong: Relabelling tempts those who think a new lot number solves the gap, but dispensers may not generate substitute transaction data, and this would break the chain of traceability DSCSA requires.

See more PTCE practice questions, answers explained.

Exam traps in Federal Requirements

Answers that look right on this material and are not. Each one is a distractor from a different question in the PTCE bank for this domain.

  • Six months from the transaction date, matching the typical short-dated stock rotation cycle.

    Why it is wrong: Tying retention to stock rotation is a plausible guess, but DSCSA sets a fixed multi-year retention period that is unrelated to product shelf life.

  • As ordinary returned stock that should be sent back to the wholesaler for credit without further internal steps

    Why it is wrong: Returning to the wholesaler may feel efficient, but treating a possible counterfeit as ordinary returns ignores the duty to investigate and quarantine, so the suspect item could re-enter the chain.

  • Dispense the remaining bottles quickly to reduce on-hand exposure before the supplier is contacted.

    Why it is wrong: This is tempting as a way to clear inventory, but dispensing suspect product to patients is exactly what DSCSA quarantine provisions are designed to prevent.

Examworthy is not affiliated with or endorsed by PTCB. Original, blueprint-aligned practice material only.